Medical Cannabis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image

New

Medical Cannabis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Report
185 Pages
May 2025
Region: Global
TechSci Research
ID: 5892155

The Medical Cannabis Market was valued at USD 28.54 Billion in 2024, and is expected to reach USD 87.41 Billion by 2030, rising at a CAGR of 20.51%. This substantial growth is driven by increased government funding, a rise in research and development initiatives, and expanding acceptance of medical cannabis worldwide. Medical cannabis refers to the therapeutic use of the cannabis plant or its derivatives to address various medical conditions such as chronic pain, anxiety, seizures, and nausea.

The market encompasses a broad spectrum of products, including dried flower, oils, capsules, tinctures, and edibles, which can be consumed in different ways based on patient needs. One of the pivotal factors fueling market expansion is the growing societal and medical acceptance of cannabis as a valid treatment alternative. The rise in favorable research outcomes and patient testimonials is further accelerating adoption. Notably, in Australia, prescriptions have soared from 1,000 in 2017 to over 100,000 in 2021 since medical cannabis was legalized in 2016.

Key Market Drivers

Regulatory Advancements and Legalization

The advancement of medical cannabis legislation globally is a key force behind market growth. Countries such as Canada, Germany, and Australia, along with numerous U.S. states, have implemented legal structures that support medical cannabis usage. For instance, in the U.S., 36 states and 4 territories have authorized its use for medical or recreational purposes. Canada’s longstanding legalization, dating back to 2001 and reinforced by the 2018 Cannabis Act, has cultivated a stable regulatory environment conducive to market expansion.

Key Market Challenges

Limited Clinical Evidence and Research Constraints

While medical cannabis continues to gain traction, a major barrier is the insufficient clinical data validating its effectiveness for various medical issues. Though initial research and anecdotal reports suggest therapeutic promise, extensive clinical studies are essential for determining standardized dosages, safety measures, and treatment efficacy. Regulatory obstacles, especially in regions like the United States where cannabis is categorized as a Schedule I substance, further impede research progression. This classification restricts study approvals and slows the accumulation of conclusive scientific evidence, making it harder for physicians to prescribe cannabis and for patients to receive consistent, data-backed treatment.

Key Market Trends

Technological Innovations and Product Diversification

The medical cannabis sector is rapidly evolving through technological innovations that enable the creation of varied product types and delivery systems. New offerings such as cannabis-based edibles, tinctures, oils, and topicals are emerging to meet diverse patient demands. These advancements not only broaden consumer choice but also support more precise and personalized medical treatments.

Key Market Players

Canopy Growth Corporation.
Aphria, Inc.
Maricann Group, Inc.
Tikun Olam - Cannabit Pharmaceuticals Ltd.
MedReleaf Corporation
GW Pharmaceuticals plc.
Cannabis Sativa, Inc.
Medical Marijuana, Inc.
Aurora Marijuana Inc.
Cronos Group Inc

Report Scope:

In this report, the Global Medical Cannabis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Cannabis Market, By Product Type:

Buds/Marijuana Flower
Cannabis Extract

Medical Cannabis Market, By Active Ingredients:

Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Others

Medical Cannabis Market, By Distribution Channel:

Medical Cannabis Market, By Application:

Chronic Pain
Mental Disorders
Cancer
Epilepsy
Others

Medical Cannabis Market, By End User Industry:

Pharmaceutical & Biotechnology Companies
Academic & Research Institutions
Others

Medical Cannabis Market, By Region:

North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global Medical Cannabis market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map

6. Global Medical Cannabis Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
6.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
6.2.3. By Distribution Channel (B2B, B2C)
6.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
6.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
6.2.6. By Region
6.2.7. By Company (2024)
6.3. Product Map
6.3.1 By Product Type
6.3.2 By Active Ingredient
6.3.3 By Distribution Channel
6.3.4 By Application
6.3.5 By End User Industry
6.3.4 By Region

7. North America Medical Cannabis Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
7.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
7.2.3. By Distribution Channel (B2B, B2C)
7.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
7.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Medical Cannabis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Active Ingredient
7.3.1.2.3. By Distribution Channel
7.3.1.2.4. By Application
7.3.1.2.5. By End User Industry
7.3.2. Canada Medical Cannabis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Active Ingredient
7.3.2.2.3. By Distribution Channel
7.3.2.2.4. By Application
7.3.2.2.5. By End User Industry
7.3.3. Mexico Medical Cannabis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Active Ingredient
7.3.3.2.3. By Distribution Channel
7.3.3.2.4. By Application
7.3.3.2.5. By End User Industry

8. Europe Medical Cannabis Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
8.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
8.2.3. By Distribution Channel (B2B, B2C)
8.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
8.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Medical Cannabis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Active Ingredient
8.3.1.2.3. By Distribution Channel
8.3.1.2.4. By Application
8.3.1.2.5. By End User Industry
8.3.2. France Medical Cannabis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Active Ingredient
8.3.2.2.3. By Distribution Channel
8.3.2.2.4. By Application
8.3.2.2.5. By End User Industry
8.3.3. United Kingdom Medical Cannabis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecasty
8.3.3.2.1. By Product Type
8.3.3.2.2. By Active Ingredient
8.3.3.2.3. By Distribution Channel
8.3.3.2.4. B y Application
8.3.3.2.5. By End User Industry
8.3.4. Italy Medical Cannabis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Active Ingredient
8.3.4.2.3. By Distribution Channel
8.3.4.2.4. By Application
8.3.4.2.5. By End User Industry
8.3.5. Spain Medical Cannabis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Active Ingredient
8.3.5.2.3. By Distribution Channel
8.3.5.2.4. By Application
8.3.5.2.5. By End User Industry

9. Asia-Pacific Medical Cannabis Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
9.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
9.2.3. By Distribution Channel (B2B, B2C)
9.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
9.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Australia Medical Cannabis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Active Ingredient
9.3.1.2.3. By Distribution Channel
9.3.1.2.4. By Application
9.3.1.2.5. By End User Industry
9.3.2. China Medical Cannabis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Active Ingredient
9.3.2.2.3. By Distribution Channel
9.3.2.2.4. By Application
9.3.2.2.5. By End User Industry
9.3.3. India Medical Cannabis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Active Ingredient
9.3.3.2.3. By Distribution Channel
9.3.3.2.4. By Application
9.3.3.2.5. By End User Industry
9.3.4. South Korea Medical Cannabis Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product Type
9.3.4.2.2. By Active Ingredient
9.3.4.2.3. By Distribution Channel
9.3.4.2.4. By Application
9.3.4.2.5. By End User Industry
9.3.5. Japan Medical Cannabis Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product Type
9.3.5.2.2. By Active Ingredient
9.3.5.2.3. By Distribution Channel
9.3.5.2.4. By Application
9.3.5.2.5. By End User Industry

10. South America Medical Cannabis Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
10.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
10.2.3. By Distribution Channel (B2B, B2C)
10.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
10.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Medical Cannabis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Active Ingredient
10.3.1.2.3. By Distribution Channel
10.3.1.2.4. By Application
10.3.1.2.5. By End User Industry
10.3.2. Argentina Medical Cannabis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Active Ingredient
10.3.2.2.3. By Distribution Channel
10.3.2.2.4. By Application
10.3.2.2.5. By End User Industry
10.3.3. Colombia Medical Cannabis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Active Ingredient
10.3.3.2.3. By Distribution Channel
10.3.3.2.4. By Application
10.3.3.2.5. By End User Industry

11. Middle East and Africa Medical Cannabis Market Outlook

11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
11.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
11.2.3. By Distribution Channel (B2B, B2C)
11.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
11.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Medical Cannabis Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Active Ingredient
11.3.1.2.3. By Distribution Channel
11.3.1.2.4. By Application
11.3.1.2.5. By End User Industry
11.3.2. Saudi Arabia Medical Cannabis Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Active Ingredient
11.3.2.2.3. By Distribution Channel
11.3.2.2.4. By Application
11.3.2.2.5. By End User Industry
11.3.3. UAE Medical Cannabis Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Active Ingredient
11.3.3.2.3. By Distribution Channel
11.3.3.2.4. By Application
11.3.3.2.5. By End User Industry

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

13.1. New Product Development
13.2. Increasing use of Medical Cannabis by the medicinal and pharmaceutical industries.

14. Global Medical Cannabis Market: SWOT Analysis

15. Porter’s Five Forces Analysis

15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products

16. Competitive Landscape

16.1. Canopy Growth Corporation.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. Aphria, Inc.
16.3. Maricann Group, Inc.
16.4. Tikun Olam - Cannabit Pharmaceuticals Ltd.
16.5. MedReleaf Corporation
16.6. GW Pharmaceuticals plc.
16.7. Cannabis Sativa, Inc.
16.8. Medical Marijuana, Inc.
16.9. Aurora Marijuana Inc.
16.10. Cronos Group Inc

17. Strategic Recommendation18. About the Publisher & Disclaimer

Companies Mentioned

Canopy Growth Corporation.
Aphria, Inc.
Maricann Group, Inc.
Tikun Olam - Cannabit Pharmaceuticals Ltd.
MedReleaf Corporation
GW Pharmaceuticals plc.
Cannabis Sativa, Inc.
Medical Marijuana, Inc.
Aurora Marijuana Inc.
Cronos Group Inc

Table Information

Report Attribute	Details
No. of Pages	185
Published	May 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 28.54 Billion
Forecasted Market Value ( USD ) by 2030	$ 87.41 Billion
Compound Annual Growth Rate	20.5%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4119EUR$4,500USD£3,454GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5035EUR$5,500USD£4,222GBP